Nurtec ODT (generic name: rimegepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist available as an orally disintegrating tablet. It is FDA-approved for both the acute treatment of migraine attacks (with or without aura) in adults and the preventive treatment of episodic migraine.

Nurtec ODT works by targeting and blocking CGRP receptors, a key pathway involved in migraine pain and inflammation. This dual benefit allows it to be taken as needed at the onset of migraine symptoms or on a regular schedule to reduce the frequency of migraine days.

The tablet dissolves quickly on or under the tongue without water, making it convenient for patients who experience nausea or difficulty swallowing during migraine attacks. Clinical studies have shown that Nurtec ODT can provide pain relief within one hour, with some patients experiencing sustained benefits for up to 48 hours.

Key Points:

• Indications: Acute migraine treatment and prevention of episodic migraine in adults.

• Formulation: Orally disintegrating tablet (no water needed).

• Mechanism: CGRP receptor antagonist.

• Benefits: Rapid relief, preventive option, convenient administration.